Idexx Laboratories Stock Probability of Future Stock Price Finishing Over 547.75
| IDXX Stock | USD 417.32 11.27 2.63% |
IDEXX |
IDEXX Laboratories Target Price Odds to finish over 547.75
The tendency of IDEXX Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 547.75 or more in 90 days |
| 417.32 | 90 days | 547.75 | near 1 |
Based on a normal probability distribution, the odds of IDEXX Laboratories to move over $ 547.75 or more in 90 days from now is near 1 (This IDEXX Laboratories probability density function shows the probability of IDEXX Stock to fall within a particular range of prices over 90 days) . Probability of IDEXX Laboratories price to stay between its current price of $ 417.32 and $ 547.75 at the end of the 90-day period is more than 93.0 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.03 . This usually indicates IDEXX Laboratories market returns are sensitive to returns on the market. As the market goes up or down, IDEXX Laboratories is expected to follow. Additionally IDEXX Laboratories has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. IDEXX Laboratories Price Density |
| Price |
Predictive Modules for IDEXX Laboratories
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as IDEXX Laboratories. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of IDEXX Laboratories' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
IDEXX Laboratories Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. IDEXX Laboratories is not an exception. The market had few large corrections towards the IDEXX Laboratories' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold IDEXX Laboratories, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of IDEXX Laboratories within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.31 | |
β | Beta against Dow Jones | 1.03 | |
σ | Overall volatility | 31.77 | |
Ir | Information ratio | -0.18 |
IDEXX Laboratories Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of IDEXX Laboratories for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for IDEXX Laboratories can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| IDEXX Laboratories generated a negative expected return over the last 90 days | |
| IDEXX Laboratories is unlikely to experience financial distress in the next 2 years | |
| IDEXX Laboratories currently holds 1.07 B in liabilities with Debt to Equity (D/E) ratio of 3.28, implying the company greatly relies on financing operations through barrowing. IDEXX Laboratories has a current ratio of 0.87, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about IDEXX Laboratories' use of debt, we should always consider it together with its cash and equity. | |
| IDEXX Laboratories has a strong financial position based on the latest SEC filings | |
| Over 94.0% of IDEXX Laboratories shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: BNP PARIBAS ASSET MANAGEMENT Holding S.A. Purchases 3,382 Shares of IDEXX Laboratories, Inc. |
IDEXX Laboratories Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of IDEXX Stock often depends not only on the future outlook of the current and potential IDEXX Laboratories' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. IDEXX Laboratories' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 84 M | |
| Cash And Short Term Investments | 453.9 M |
IDEXX Laboratories Technical Analysis
IDEXX Laboratories' future price can be derived by breaking down and analyzing its technical indicators over time. IDEXX Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of IDEXX Laboratories. In general, you should focus on analyzing IDEXX Stock price patterns and their correlations with different microeconomic environments and drivers.
IDEXX Laboratories Predictive Forecast Models
IDEXX Laboratories' time-series forecasting models is one of many IDEXX Laboratories' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary IDEXX Laboratories' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about IDEXX Laboratories
Checking the ongoing alerts about IDEXX Laboratories for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for IDEXX Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| IDEXX Laboratories generated a negative expected return over the last 90 days | |
| IDEXX Laboratories is unlikely to experience financial distress in the next 2 years | |
| IDEXX Laboratories currently holds 1.07 B in liabilities with Debt to Equity (D/E) ratio of 3.28, implying the company greatly relies on financing operations through barrowing. IDEXX Laboratories has a current ratio of 0.87, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about IDEXX Laboratories' use of debt, we should always consider it together with its cash and equity. | |
| IDEXX Laboratories has a strong financial position based on the latest SEC filings | |
| Over 94.0% of IDEXX Laboratories shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: BNP PARIBAS ASSET MANAGEMENT Holding S.A. Purchases 3,382 Shares of IDEXX Laboratories, Inc. |
Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.